Evidence 1
Activity
Activity
0% Hemolysis
Toxicity
25 µM
Hemolytic
Cytotoxic
0% Hemolysis | 25 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Novel designed VmCT1 analogs with increased antimicrobial activity. | Eur J Med Chem | 2017